Hematology & Oncology Doctors in Altamonte Springs, FL Accepting Medicare

6 Hematology & Oncology doctors found. Showing 1 - 6

Robert B Reynolds, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 894 E Altamonte Dr, Altamonte Springs, FL 32701 Phone: 407-834-5151    Fax: 407-834-5562

Raul C Castillo, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 894 E Altamonte Dr, Altamonte Springs, FL 32701 Phone: 407-834-5151    Fax: 407-896-1926

Dr. Wassim Mchayleh, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 894 E Altamonte Dr, Altamonte Springs, FL 32701 Phone: 407-834-5151    Fax: 407-834-5562

Ahmed Zakari, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 894 E Altamonte Dr, Altamonte Springs, FL 32701 Phone: 407-834-5151    Fax: 407-834-5562

Linda F Lukman, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 661 E Altamonte Dr, Suite 312, Altamonte Springs, FL 32701 Phone: 407-834-5151    Fax: 407-834-5562

Dr. Paul Robert Garrett Jr., MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 115 Boston Ave, Suite 2300, Altamonte Springs, FL 32701 Phone: 407-975-3663    Fax: 407-260-6702

News Archive

Meridian Bioscience revises fiscal 2010 guidance, expects net sales between $145M and $153M

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010. This action is being taken as a result of weaker than expected operating results for the second quarter ending March 31, 2010, based on preliminary results to date. Separately, Meridian announced that it will file a 510(k) for FDA marketing clearance next week in connection with its illumigene™ C. difficile product.

Premier international conference to discuss latest diagnostic tools, emerging therapies for personalized medicine

What As scientists understand more about a tumor's underlying biology, personalized medicine is emerging as the new patient management paradigm. This year, the American Association for Cancer Research will host its fourth Molecular Diagnostics in Cancer Therapeutic Development: Challenges and Horizons conference at the Sheraton Denver Downtown Hotel in Denver, Colo. This meeting regularly draws representatives from academia and industry to discuss the latest in diagnostic tools and emerging therapies.

Administration of N2O + ISO appears to have negative effect on fetal development

An anesthetic regimen typically used during surgery on pregnant mothers appears to have a negative effect on the development of the fetus, according to a new study on mice conducted by neurobiologists from the National Center for Toxicological Research, in Arizona.

Researchers develop ultrapotent miniproteins that target SARS-CoV-2 receptor-binding domain

Researchers have investigated the effectiveness of a bioengineered miniprotein in protecting against SARS-CoV-2 infection in vivo. The researchers evaluated the miniprotein, LCB1, against SARS-CoV-2-mediated lung disease in human ACE2-expressing transgenic mice.

Read more Medical News

› Verified 4 days ago